Evidence map›Paper›PMID 42584416›Full record

ReviewJournal of bacteriology2026

Sara N Stoner, Ana Fairbanks-Mahnke, Sarah E Clark

Abstract readReview
In one paragraph

Review in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara N StonerDepartment of Otolaryngology-Head & Neck Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0000-0002-9350-9441
Ana Fairbanks-MahnkeDepartment of Otolaryngology-Head & Neck Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA.
Sarah E ClarkDepartment of Otolaryngology-Head & Neck Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0000-0002-5975-5032

Funding

TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Airway Prevotella enhance innate immune-mediated protection against lung infectionR01AI172958 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Sarah E Clark · 2023 to 2026
$2.0M
Cystic Fibrosis Foundation CLARK25G0National Institute of Allergy and Infectious Diseases R01AI172958National Institute of Allergy and Infectious Diseases T32AI007405NIAID NIH HHS R01 AI172958NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacteroidaceae InfectionsHost-Pathogen InteractionsLungPrevotellaAnimalsHomeostasisHumansImmunity, InnateMicrobiotaPneumonia, Bacterialbacterial infectionCFCOPDlung microbiomepneumoniaPrevotella

Identifiers

PMID42584416
PMCPMC13584745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.